136 related articles for article (PubMed ID: 175023)
21. Epstein-Barr virus: the spectrum of its manifestations in human beings.
Purtilo DT
South Med J; 1987 Aug; 80(8):943-7. PubMed ID: 3039669
[TBL] [Abstract][Full Text] [Related]
22. Detection of Epstein-Barr virus DNA in human tumors.
Nonoyama M; Kawai Y; Pagano JS
Bibl Haematol; 1975; (40):577-83. PubMed ID: 169825
[TBL] [Abstract][Full Text] [Related]
23. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
24. The Epstein-Barr virus.
Henle W; Henle G; Lennette ET
Sci Am; 1979 Jul; 241(1):48-59. PubMed ID: 221971
[No Abstract] [Full Text] [Related]
25. Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates.
Fischer DK; Miller G; Gradoville L; Heston L; Westrate MW; Maris W; Wright J; Brandsma J; Summers WC
Cell; 1981 May; 24(2):543-53. PubMed ID: 6263500
[TBL] [Abstract][Full Text] [Related]
26. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
27. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.
Bornkamm GW; Delius H; Zimber U; Hudewentz J; Epstein MA
J Virol; 1980 Sep; 35(3):603-18. PubMed ID: 6252328
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
Razzouk BI; Srinivas S; Sample CE; Singh V; Sixbey JW
J Infect Dis; 1996 Mar; 173(3):529-35. PubMed ID: 8627013
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
Hewetson JF; Rocchi G; Henle W; Henle G
J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
[No Abstract] [Full Text] [Related]
31. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
[TBL] [Abstract][Full Text] [Related]
32. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line.
Koliais S; Bjursell G; Adams A; Lindahl T; Klein G
J Natl Cancer Inst; 1978 May; 60(5):991-4. PubMed ID: 205666
[TBL] [Abstract][Full Text] [Related]
33. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization.
Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J
Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
Henle W; Henle G
Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus (EBV) specific T and K cell cytotoxicity in vitro.
Jondal M; Svedmyr E; Klein E; Klein G
Bibl Haematol; 1975 Oct; (43):265-9. PubMed ID: 183683
[No Abstract] [Full Text] [Related]
36. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
Sairenji T; Sullivan JL; Humphreys RE
J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infections.
Middleton PJ
Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
[No Abstract] [Full Text] [Related]
38. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
39. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
[TBL] [Abstract][Full Text] [Related]
40. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
